Coco Gauff Critiques WTA’s Gene-Testing Policy

Coco Gauff has expressed concerns over the recently implemented gene-testing policy by the WTA Tour. As a two-time Grand Slam champion, she recognizes the reasoning behind the policy but disapproves of the politicization and resulting animosity towards the transgender community.

Speaking at the Canadian Open in Toronto after her victory against Kayla Day, Gauff emphasized the importance of a nuanced approach to the topic. She stated, So, yes, I guess I kind of agree with trying to protect the fairness in women’s sports. But I also do not like the attack that it is creating, highlighting that criticism of the policy might be used to unfairly target the transgender community.

The Women’s Tennis Association introduced mandatory gene-testing last month, requiring players to test for the SRY gene to qualify for the 2028 Los Angeles Olympics. The SRY gene is part of the DNA that influences male sex development.

There is currently uncertainty regarding the presence of transgender women at Olympic levels in tennis, which adds to the complexity of the issue. The WTA clarified that the policy aims to differentiate between biological sex and gender identity and intends no disrespect towards individuals’ gender identities.

Critics, including human rights experts and activist groups, have openly opposed mandatory gender screenings. Gauff pointed out the potential for improved transparency, noting that many players were unaware of the policy until its official announcement.